EconPapers    
Economics at your fingertips  
 

Aspartame and Platelets in Type II Diabetic Patients

Arbind Kumar Choudhary

European Journal of Medical and Health Sciences, 2022, vol. 4, issue 3, 52-56

Abstract: Background: For type II diabetes (T2D) subjects to better regulate carbohydrate consumption and manage blood glucose levels, a non-nutritive sweetener (aspartame) is prescribed as an alternative to natural sugar. Previous studies show that there was a 68% rise in the probability of aspartame consumers developing T2D compared with non-consumers. In diabetes and inflammation, deformed red blood cells (RBCs) and atypical fibrin fibre formation or an altered fibrin structure are especially prevalent. Objective: The aim of this study was to investigate, in subjects with T2D taking aspartame, clot viscoelasticity and platelet structure. Methodology: Blood was drawn from 12 T2D subjects from the diabetic clinic at the Steve Biko Academic Hospital, South Africa. Blood was used to perform a full blood count, thromboelastography (TEG) and scanning electron microscopy (SEM). Results: SEM showed increased platelet activation and abnormal TEG parameters in T2D consuming aspartame. Conclusion: A hypercoagulable state can increase the risk of thromboembolic complications and an increased incidence of vascular disease. This knowledge may be used to build awareness among consumers of aspartame.

Keywords: Aspartame; blood; coagulation; diabetes; platelets (search for similar items in EconPapers)
Date: 2022
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://eu-opensci.org/index.php/ejmed/article/view/41306 Abstract page (text/html)
https://eu-opensci.org/index.php/ejmed/article/download/41306/9491 Full text (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:epw:ejmed0:v:4:y:2022:i:3:id:41306

DOI: 10.24018/ejmed.2022.4.3.1306

Access Statistics for this article

More articles in European Journal of Medical and Health Sciences from European Open Science
Bibliographic data for series maintained by Support ().

 
Page updated 2026-08-01
Handle: RePEc:epw:ejmed0:v:4:y:2022:i:3:id:41306